Between‐Visit Reproducibility of Shear Wave Viscoelastography in Volunteers and Patients With Metabolic Dysfunction‐Associated Steatotic Liver Disease

Objective To assess the reproducibility of six ultrasound (US)‐determined shear wave (SW) viscoelastography parameters for assessment of mechanical properties of the liver in volunteers and patients with biopsy‐proven metabolic dysfunction‐associated steatotic liver disease (MASLD) or metabolic dysf...

Full description

Saved in:
Bibliographic Details
Published inJournal of ultrasound in medicine Vol. 43; no. 11; pp. 2095 - 2108
Main Authors Yazdani, Ladan, Selladurai, Sathiyamoorthy, Rafati, Iman, Bhatt, Manish, Montagnon, Emmanuel, Chayer, Boris, Olivié, Damien, Giard, Jeanne‐Marie, Sebastiani, Giada, Nguyen, Bich N., Cloutier, Guy, Tang, An
Format Journal Article
LanguageEnglish
Published Hoboken, USA John Wiley & Sons, Inc 01.11.2024
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Objective To assess the reproducibility of six ultrasound (US)‐determined shear wave (SW) viscoelastography parameters for assessment of mechanical properties of the liver in volunteers and patients with biopsy‐proven metabolic dysfunction‐associated steatotic liver disease (MASLD) or metabolic dysfunction‐associated steatohepatitis (MASH). Methods This prospective, cross‐sectional, institutional review board‐approved study included 10 volunteers and 20 patients with MASLD or MASH who underwent liver US elastography twice, at least 2 weeks apart. SW speed (SWS), Young's modulus (E), shear modulus (G), SW attenuation (SWA), SW dispersion (SWD), and viscosity were computed from radiofrequency data recorded on a research US scanner. Linear mixed models were used to consider the sonographer on duty as a confounder. The reproducibility of measurements was assessed by intraclass correlation coefficient (ICC), coefficient of variation (CV), reproducibility coefficient (RDC), and Bland‐Altman analyses. Results The sonographer performing the exam had no impact on viscoelastic parameters (P > .05). ICCs of SWS, E, G, SWA, SWD, and viscosity were, respectively, 0.89 (95% confidence intervals [CI]: 0.79‐0.95), 0.81 (95% CI: 0.79‐0.95), 0.90 (95% CI: 0.80‐0.95), 0.96 (95% CI: 0.93‐0.98), 0.78 (95% CI: 0.60‐0.89), and 0.90 (95% CI: 0.80‐0.95); CVs were 11.9, 23.3, 24.2, 10.1, 29.0, and 32.2%; RDCs were 33.0, 64.5, 66.9, 27.7, 80.3, and 89.2%, and Bland‐Altman mean biases and 95% limits of agreement were −0.05 (−0.45, 0.35) m/s, −0.61 (−5.33, 4.10) kPa, −0.25 (−2.06, 1.56) kPa, −0.01 (−0.27, 0.26) Np/m/Hz, −0.09 (−7.09, 6.91) m/s/kHz, and −0.33 (−2.60, 1.94) Pa/s, between the two visits. Conclusion US‐determined viscoelastography parameters can be measured with high reproducibility and consistency between two visits 2 weeks apart on the same ultrasound machine.
Bibliography:Guy Cloutier and An Tang share joint senior author contributions.
Giada Sebastiani has acted as a Speaker for Pfizer, Merck, Novo Nordisk, Gilead, and AbbVie; served as an advisory board member for Merck, Gilead, Pfizer, Novo Nordisk, and Intercept; and has received unrestricted research funding from Theratechnologies Inc. An Tang and Guy Cloutier have received equipment loans and grant funding supports from Siemens Healthineers.
This work was supported by the Natural Sciences and Engineering Research Council of Canada (Grant No. 2022‐03729), the Canadian Institutes of Health Research (Grant No. 389385), and the Onco‐Tech Consortium (Oncopole, Medteq, Transmedtech, Cancer Research Society, Fonds de Recherche Santé du Québec, and Siemens Healthineers) (Grant No. 293741). Giada Sebastiani is supported by a Senior Salary Award from Fonds de Recherche du Québec – Santé (FRQS) (Grant No. 296306). An Tang is supported by a Senior Salary Award by the FRQS and Fondation de l'Association des radiologistes du Québec (FRQS‐FARQ Grant No. 298509).
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0278-4297
1550-9613
1550-9613
DOI:10.1002/jum.16538